New bill may allow FDA user fees to be exempt from sequestration, i.e. used as user fees
The FDA may be freed up to put its user fees to use for product review for medical devices and drugs, if a bipartisan bill introduced in the House passes. In essence, the bill exempts the FDA user fees from sequestration and may take one burden off the already slow approval process. That adds up […]